Capecitabine dosing is not yet optimized for breast cancer. uri icon

Overview

publication date

  • May 25, 2010

Research

keywords

  • Antimetabolites, Antineoplastic
  • Breast Neoplasms
  • Deoxycytidine
  • Fluorouracil
  • Prodrugs

Identity

Scopus Document Identifier

  • 77958498240

Digital Object Identifier (DOI)

  • 10.1093/annonc/mdq264

PubMed ID

  • 20501505

Additional Document Info

volume

  • 21

issue

  • 11